NeuroDex, Inc.

11:00 AM - 12:00 PM (PDT), Thursday, June 16, 2022
A brain liquid biopsy company, leveraging our proprietary blood based, cell-specific exosome isolation technology to created diagnostics for critical unmet neurological needs, and assisting companies in advancing their therapies to approval.
Speaker
photo
CEO
NeuroDex, Inc.